Evidence map›Paper›PMID 29791744›Full record

ArticleBritish journal of pharmacology2018

PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.

Lingxin Wang, Shannon G Zellmer, David M Printzenhoff, Neil A Castle

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lingxin WangDepartment of Molecular and Cellular Physiology, Stanford University, Stanford, CA, USA.
Shannon G ZellmerIcagen Inc., Durham, NC, 27703, USA.
David M PrintzenhoffIcagen Inc., Durham, NC, 27703, USA.
Neil A CastleIcagen Inc., Durham, NC, 27703, USA.ORCID 0000-0002-2653-4794
Wave Computation Technologies (United States) · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePharmacological agents that either inhibit or enhance flux of ions through voltage-gated sodium (Na EXPERIMENTAL APPROACH: Electrophysiology and site-directed mutation were used to investigate the effects of PF-06526290 on Na KEY

resultsPF-06526290 greatly slows inactivation of Na CONCLUSIONS AND IMPLICATIONS: These findings suggest that distinct interactions may underlie the two modes of Na

Indexed as

AnimalsBenzenesulfonamidesCHO CellsCricetulusGanglia, SpinalHEK293 CellsHumansMiceNeuronsSulfonamidesThiazolesVoltage-Gated Sodium Channel AgonistsVoltage-Gated Sodium Channel BlockersVoltage-Gated Sodium ChannelsBenzenesulfonamidesPF-06526290SulfonamidesThiazolesVoltage-Gated Sodium Channel AgonistsVoltage-Gated Sodium Channel BlockersVoltage-Gated Sodium Channels

Identifiers

PMID29791744
PMCPMC6016627
OpenAlexW2803449444

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.